Table 1 Studies using array-CGH on breast cancer samples or breast cancer cell lines
Patient source or cell line | Array platform | Resolution (Mb) | Ref. |
|---|---|---|---|
2 Human cell lines, inclusing breast (BT474) | 18,664 oligo nucleotides | ~0.15 | [16] |
BC (n = 5) | 32 k tiling BAC | Sub-Mb | [17] |
Primary BC (n = 33), BC cell line (n = 27) | Genome-wide BAC and high resolution on 8p11-12 | ~1.5 | [18] |
FFPE BC (n = 44) | 4153 BAC | <1 | [24] |
Comparison of FFPE with frozen BC | 2464 BAC | 1.5 | [27] |
Gain in 47% BC (unpublished results) | See Pinkel and coworkers [2] | Â | [32] |
FFPE BC (n = 31) | 471 BAC/PAC | 15 | [47] |
BRCA1 (n = 14), BRCA2 (n = 12), sporadic (n = 26) | 3.5 k BAC | 1 | [58] |
1 Case report | 1777 BAC | ~1.5 | [66] |
24 pairs LCIS + ILC | ~2400 BAC | 1.5 | [68] |
4 synchronous tumours (2 BC and 2 leiomyosarcomas) | 2.5 k BAC | 1.5 | [70] |
BC cell line (n = 1) | 6 k BAC | <1 | [93] |
11 BC cell lines | 2464 BAC (Hum-Array1.14) | 1.5 | [95] |
52 node-negative invasive BC | 57 oncogene loci (AmpliOncâ„¢) | Â | [96] |
Premenopausal BC and radiation (n = 47) | 3.5 k BAC | 1 | [107] |
16 cell lines (8 of them BC) | 9862 SNPs | Â | [108] |
2 BC cell lines | 2560 BAC | 1.5 | [109] |
47 fresh-frozen IDC BC | 4134 BAC | 0.9 | [110] |